Synergy Pharmaceuticals Stock Price Down 6.3% on Disappointing Earnings (SGYP)
Shares of Synergy Pharmaceuticals (NASDAQ:SGYP) fell 6.3% on Tuesday following a dissappointing earnings announcement, Analyst Ratings Net reports. The company traded as low as $3.50 and last traded at $3.55, with a volume of 494,869 shares trading hands. The stock had previously closed at $3.79.
The company reported ($0.28) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.23) by $0.05.
Separately, analysts at Aegis reiterated a “positive” rating on shares of Synergy Pharmaceuticals in a research note on Tuesday, July 8th.
The stock’s 50-day moving average is $3.8 and its 200-day moving average is $4.62. The company’s market cap is $336.4 million.
Synergy Pharmaceuticals, Inc is a biopharmaceutical company focused primarily on the development of drugs to treat gastrointestinal (NASDAQ:SGYP), disorders and diseases.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.